ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Darzalex 100mg/5ml, Konzentrat zur Herstellung einer Infusionslösung - 
66072003 Janssen-Cilag AG
Darzalex 100mg/5ml, Konzentrat zur Herstellung einer Infusionslösung06.12.2016
  27.01.2023
(L01FC01) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
404.57Yes
    
10 %456.40
  
7680660720031Biotechnologika
  
Composition
daratumumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 273.3 mg, methioninum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Daratumumabum100mg / 5ml
BAG: Active AgentDose
Daratumumabum100 mg
 
Inactive agentsDose
Histidin Hydrochloride Monohydrate 
Histidine 
Methionine 
Polysorbatum 20 
Sorbitol273.3mg / 5ml
 
Source
Data was imported : 14.04.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home